Sign in
4

Changes in Ownership

Immunovant, Inc. Filed Acc 0001764013-26-000032

Chief Financial Officer acquired 64,968 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Girao Tiago Chief Financial Officer 2026-04-07 Grant or award +64,968 273,356 D
Derivatives
Girao Tiago Chief Financial Officer 2026-04-07 Grant or award · Stock Option (right to buy) +94,002 94,002 D
Loading xslF345X06/wk-form4_1775765429.xml…